Category:
Description:
Indications:
Contraindications:
-
Tachydysrhythmias;
as sole treatment of status asthmaticus
-
Active
peptic ulcer disease, seizure disorders
Precautions:
-
Pregnancy
category C; no reports of malformations; compatible with breast
feeding with precaution that rapidly absorbed preparations may cause
irritability in the infant
-
Elderly,
CHF, cor pulmonale
-
Hepatic
disease, diabetes mellitus
-
Hyperthyroidism,
hypertension, active alcoholism, children, neonates
Adverse
Reactions (Side Effects):
-
CNS:
anxiety, dizziness, headache, insomnia, lightheadedness, muscle
twitching, restlessness, seizures
-
CV:
dysrhythmias, fluid retention with tachycardia, hypotension,
palpitations, pounding heartbeat, sinus tachycardia
-
GI:
anorexia, bitter taste, diarrhea, dyspepsia, gastroesophageal reflux,
nausea, vomiting
-
GU:
urinary frequency
-
RESP:
increased rate
-
SKIN:
flushing, urticaria
|
Dosage:
Administered
orally, intravenously: Dose based on body weight. When converting to
sustained release products, total daily dose remains the same but is
divided every 8-24 hours depending on product and dose (doses >1200mg
daily should be divided every 8 hours, doses <1200mg daily can be given
every 12 hours
Drug
interactions:
-
Enoxacin,
fluoxamine, mexiletine, propranolol, troleandomycin: increased
theophylline levels
-
Allopurinol,
amiodarone,m cimetadine, ciprofloxacin, disulfiram, erythromycin,
interferon alpha, isoniazid, metoprolol, norfloxacin, pentoxyfylline,
propafenone, radioactive iodine, tacrine, thiabendazole, ticlopidine,
verapamil: increased theophylline levels
-
Smoking:
increased theophylline requirements
-
Aminoglutethamide,
barbiturates, carbamazepine, phenytoin, rifampin, ritonavir, thyroid
hormone: reduced theophylline levels; decreased serum phenytoin levels
|
The information contained here is an abbreviated summary. For more detailed
and complete information, consult the manufacturer's product information sheets
or standard textbooks.
Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department
of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300
OB-GYN 101:
Introductory Obstetrics & Gynecology
© 2003, 2004, 2005, 2008
Brookside Associates, LLC
All rights reserved
|